Cargando…

Efficient HIV-1 Trans Infection of CD4(+) T Cells Occurs in the Presence of Antiretroviral Therapy

BACKGROUND: Antiretroviral therapy (ART) has dramatically improved the quality of life of people with HIV-1 infection (PWH). However, it is not curative, and interruption of ART results in rapid viral rebound. Cell-to-cell transfer of HIV-1, or trans infection, is a highly efficient mechanism of vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rappocciolo, Giovanna, Sluis-Cremer, Nicolas, Rinaldo, Charles R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613953/ https://www.ncbi.nlm.nih.gov/pubmed/31304185 http://dx.doi.org/10.1093/ofid/ofz253

Ejemplares similares

B Lymphocytes, but Not Dendritic Cells, Efficiently HIV-1 Trans Infect Naive CD4(+) T Cells: Implications for the Viral Reservoir
por: Gerberick, Abigail, et al.
Publicado: (2021)

Inefficient HIV-1 trans Infection of CD4(+) T Cells by Macrophages from HIV-1 Nonprogressors Is Associated with Altered Membrane Cholesterol and DC-SIGN
por: DeLucia, Diana C., et al.
Publicado: (2018)

Alterations in Cholesterol Metabolism Restrict HIV-1 Trans Infection in Nonprogressors
por: Rappocciolo, Giovanna, et al.
Publicado: (2014)

Human Immunodeficiency Virus (HIV)–Infected CCR6(+) Rectal CD4(+) T Cells and HIV Persistence On Antiretroviral Therapy
por: Anderson, Jenny L, et al.
Publicado: (2020)

Transcriptional Changes in CD8(+) T Cells During Antiretroviral Therapy Intensified With Raltegravir
por: Ouyang, Zhengyu, et al.
Publicado: (2015)

Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial
por: Baker, Jason V., et al.
Publicado: (2016)

CD4 Variability in Malawi: Implications for Use of a CD4 Threshold of 500 Cells/mm(3) Versus Universal Eligibility for Antiretroviral Therapy
por: Schooley, Alan L., et al.
Publicado: (2016)

Racial Disparities in Virologic Failure and Tolerability During Firstline HIV Antiretroviral Therapy
por: Bhagwat, Priya, et al.
Publicado: (2019)

CD4 regulatory T cells Control CD8 T cell responses to human Herpesvirus 8 lytic and latency proteins
por: Lepone, Lauren, et al.
Publicado: (2012)

Cannabis Use Is Associated With Decreased Antiretroviral Therapy Adherence Among Older Adults With HIV
por: Manuzak, Jennifer A, et al.
Publicado: (2023)

Recommended First-Line Antiretroviral Therapy Regimens and Risk of Diabetes Mellitus in HIV-Infected Adults in Resource-Limited Settings
por: Paengsai, Ninutcha, et al.
Publicado: (2019)

Patterns of Co-occurring Comorbidities in People Living With HIV
por: De Francesco, Davide, et al.
Publicado: (2018)

Monitoring HIV infection in Minas Gerais state: 15-year assessment of adults living with HIV initiating Antiretroviral Therapy
por: Mendicino, Cássia Cristina Pinto, et al.
Publicado: (2020)

Oral Cytokine Levels Are More Linked to Levels of Plasma and Oral HIV-1 RNA Than to CD4(+) T-Cell Counts in People With HIV
por: Rocco, Joseph M, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Associates With Unstable Housing and Occurs in the Presence of Antibodies
por: Bean, David J, et al.
Publicado: (2021)

Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2021)

Evolution of Drug Interactions With Antiretroviral Medication in People With HIV
por: El Moussaoui, Majdouline, et al.
Publicado: (2020)

HIV-1 Trans Infection of CD4(+) T Cells by Professional Antigen Presenting Cells
por: Rinaldo, Charles R.
Publicado: (2013)

Antiretroviral Therapy as Prevention of … Pneumococcal Infections?
por: Lesourd, Anaïs, et al.
Publicado: (2016)

CD4 Recovery on Antiretroviral Therapy Is Associated With Decreased Progression to Liver Disease Among Hepatitis C Virus-Infected Injecting Drug Users
por: Anderson, Jeffrey P., et al.
Publicado: (2015)

Intensifying Antiretroviral Therapy With Raltegravir and Maraviroc During Early Human Immunodeficiency Virus (HIV) Infection Does Not Accelerate HIV Reservoir Reduction
por: Ostrowski, Mario, et al.
Publicado: (2015)

Prevalence of Cardiometabolic Disease Risk Factors in People With HIV Initiating Antiretroviral Therapy at a High-Volume HIV Clinic in Kampala, Uganda
por: Amutuhaire, Willington, et al.
Publicado: (2023)

Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy–Naïve and –Experienced Patients in Sub-Saharan Africa
por: Kalata, Newton, et al.
Publicado: (2021)

High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana
por: Ryan, Kathleen, et al.
Publicado: (2017)

Clinical Outcomes Following the Use of Archived Proviral HIV-1 DNA Genotype to Guide Antiretroviral Therapy Adjustment
por: Ellis, Kristen E, et al.
Publicado: (2019)

A Randomized, Placebo-Controlled Trial Assessing the Effect of VISBIOME ES Probiotic in People With HIV on Antiretroviral Therapy
por: Presti, Rachel M, et al.
Publicado: (2021)

Cryptococcal Antigen Screening Among Antiretroviral Therapy–Experienced People With HIV With Viral Load Nonsuppression in Rural Uganda
por: Baluku, Joseph Baruch, et al.
Publicado: (2021)

Outcomes and Predictors of Rapid Antiretroviral Therapy Initiation for People With Newly Diagnosed HIV in an Integrated Health Care System
por: Dalal, Avani, et al.
Publicado: (2023)

The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment
por: Kamal, Susan, et al.
Publicado: (2017)

Human Immunodeficiency Virus (HIV) Treatment With Antiretroviral Therapy Mitigates the High Risk of Mental Health Disorders Associated With HIV Infection in the US Population
por: Ba, Djibril M, et al.
Publicado: (2023)

Increased Regulatory T-Cell Percentage Contributes to Poor CD4(+) Lymphocytes Recovery: A 2-Year Prospective Study After Introduction of Antiretroviral Therapy
por: Saison, Julien, et al.
Publicado: (2015)

Systemic Cytokine Levels Do Not Predict CD4(+) T-Cell Recovery After Suppressive Combination Antiretroviral Therapy in Chronic Human Immunodeficiency Virus Infection
por: Norris, Philip J., et al.
Publicado: (2016)

Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study
por: Elzi, Luigia, et al.
Publicado: (2016)

Tuberculosis Incidence and Risk Factors Among Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy in a Large HIV Program in Nigeria
por: Chang, Charlotte A., et al.
Publicado: (2015)

First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic
por: Christopoulos, Katerina A, et al.
Publicado: (2022)

Slow CD4(+) T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana
por: Anderson, Motswedi, et al.
Publicado: (2016)

Factors Associated With Persistence of Plasma HIV-1 RNA During Long-term Continuously Suppressive Firstline Antiretroviral Therapy
por: Ruggiero, Alessandra, et al.
Publicado: (2018)

Risk and Cost Associated With Drug–Drug Interactions Among Aging HIV Patients Receiving Combined Antiretroviral Therapy in France
por: Demessine, Ludivine, et al.
Publicado: (2019)

Mortality Over Long-term Follow-up for People With HIV Receiving Longitudinal Care and Antiretroviral Therapy in Rural Haiti
por: Richterman, Aaron, et al.
Publicado: (2020)

Monitoring Circulating Immune Checkpoint Proteins as Predictors of Non-AIDS Morbid Events in People With HIV Initiating Antiretroviral Therapy
por: Premeaux, Thomas A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_us368af6ipbpndpe6l0pnt8tbu